QGA
TLSIW icon

Q Global Advisors’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Q Global Advisors’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-49,561
Closed -$13K – 274
2022
Q1 		$13K Sell
49,561
-22,349
-31% -$9.61K 0.01% 289
2021
Q4 		$37K Buy
+71,910
New +$66K 0.01% 246

Other funds holding TLSIW

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
IM
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

Q Global Advisors's TLSIW Position: Q2 2022 in Review

Q Global Advisors sold out of TriSalus Life Sciences Warrant (TLSIW) in Q2 2022, closing a stake of 49,561 shares — an estimated $13K sold.

Q Global Advisors first reported a position in TLSIW in Q4 2021 and held it in 2 quarters. The position peaked at $37K in Q4 2021. 30 funds tracked by Wall St. Rank hold TLSIW as of Q2 2022.

  • Q Global Advisors reported no remaining TriSalus Life Sciences Warrant position as of Q2 2022 after selling out during the quarter.
  • Q Global Advisors sold 49,561 TriSalus Life Sciences Warrant shares in Q2 2022, an estimated $13K.
  • Q Global Advisors first reported a position in TriSalus Life Sciences Warrant in Q4 2021 and held it in 2 quarters.
  • Q Global Advisors's TriSalus Life Sciences Warrant position peaked at $37K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q2 2022.

Based on Q Global Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.